Soleno Therapeutics (SLNO) EPS (Basic): 2013-2024
Historic EPS (Basic) for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to -$4.38.
- Soleno Therapeutics' EPS (Basic) rose 79.90% to -$0.40 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.78, marking a year-over-year increase of 99.20%. This contributed to the annual value of -$4.38 for FY2024, which is 85.59% down from last year.
- According to the latest figures from FY2024, Soleno Therapeutics' EPS (Basic) is -$4.38, which was down 85.59% from -$2.36 recorded in FY2023.
- Soleno Therapeutics' 5-year EPS (Basic) high stood at -$2.36 for FY2023, and its period low was -$4.38 during FY2024.
- Over the past 3 years, Soleno Therapeutics' median EPS (Basic) value was -$2.87 (recorded in 2022), while the average stood at -$3.20.
- As far as peak fluctuations go, Soleno Therapeutics' EPS (Basic) increased by 17.77% in 2023, and later tumbled by 85.59% in 2024.
- Yearly analysis of 3 years shows Soleno Therapeutics' EPS (Basic) stood at -$2.87 in 2022, then climbed by 17.77% to -$2.36 in 2023, then tumbled by 85.59% to -$4.38 in 2024.